Cargando…

Mexiletine Differentially Restores the Trafficking Defects Caused by Two Brugada Syndrome Mutations

The human cardiac sodium channel Na(v)1.5 encoded by the SCN5A gene plays a critical role in cardiac excitability and the propagation of action potentials. Na(v)1.5 dysfunctions due to mutations cause cardiac diseases such as the LQT3 form of long QT syndrome, conduction disorders, and Brugada syndr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moreau, Adrien, Keller, Dagmar I., Huang, Hai, Fressart, Véronique, Schmied, Christian, Timour, Quadiri, Chahine, Mohamed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2012
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3330751/ https://www.ncbi.nlm.nih.gov/pubmed/22529811 http://dx.doi.org/10.3389/fphar.2012.00062

Ejemplares similares

Sudden Death of Cardiac Origin and Psychotropic Drugs
por: Timour, Quadiri, et al.
Publicado: (2012)

Mutations in the Voltage Sensors of Domains I and II of Na(v)1.5 that are Associated with Arrhythmias and Dilated Cardiomyopathy Generate Gating Pore Currents
por: Moreau, Adrien, et al.
Publicado: (2015)

Biophysics, pathophysiology, and pharmacology of ion channel gating pores
por: Moreau, Adrien, et al.
Publicado: (2014)

Gating Properties of Mutant Sodium Channels and Responses to Sodium Current Inhibitors Predict Mexiletine-Sensitive Mutations of Long QT Syndrome 3
por: Li, Gang, et al.
Publicado: (2020)

Sodium overload due to a persistent current that attenuates the arrhythmogenic potential of a novel LQT3 mutation
por: Moreau, Adrien, et al.
Publicado: (2013)

Molecular Insights into the Local Anesthetic Receptor within Voltage-Gated Sodium Channels Using Hydroxylated Analogs of Mexiletine
por: Desaphy, Jean-François, et al.
Publicado: (2012)

Anti-Bronchospasmodic Effect of JME-173, a Novel Mexiletine Analog Endowed With Highly Attenuated Anesthetic Activity
por: Carvalho, Katharinne Ingrid Moraes, et al.
Publicado: (2020)

Expression defect of the rare variant/Brugada mutation R1512W depends upon the SCN5A splice variant background and can be rescued by mexiletine and the common polymorphism H558R
por: Hu, Rou-Mu, et al.
Publicado: (2021)

Dual Action of Mexiletine and Its Pyrroline Derivatives as Skeletal Muscle Sodium Channel Blockers and Anti-oxidant Compounds: Toward Novel Therapeutic Potential
por: De Bellis, Michela, et al.
Publicado: (2018)

Novel G1481V and Q1491H SCN5A Mutations Linked to Long QT Syndrome Destabilize the Nav1.5 Inactivation State
por: Plumereau, Quentin, et al.
Publicado: (2020)

A patient with mexiletine-related psychosis
por: Shailesh, Fnu, et al.
Publicado: (2011)

Gating pore currents are defects in common with two Na(v)1.5 mutations in patients with mixed arrhythmias and dilated cardiomyopathy
por: Moreau, Adrien, et al.
Publicado: (2015)

Decreasing Poly(ADP-Ribose) Polymerase Activity Restores ΔF508 CFTR Trafficking
por: Anjos, Suzana M., et al.
Publicado: (2012)

Experience with oral mexiletine in primary erythromelalgia in children
por: Iqbal, Javeed, et al.
Publicado: (2009)

Molecular Modeling of Cardiac Sodium Channel with Mexiletine
por: Zhorov, Boris S.
Publicado: (2022)

A leaky voltage sensor domain of cardiac sodium channels causes arrhythmias associated with dilated cardiomyopathy
por: Moreau, Adrien, et al.
Publicado: (2018)

Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation
por: Liu, Guizhi, et al.
Publicado: (2017)

Reduced current density, partially rescued by mexiletine, and depolarizing shift in activation of SCN5A W374G channels as a cause of severe form of Brugada syndrome
por: Nakajima, Tadashi, et al.
Publicado: (2021)

Brugada ECG pattern: a physiopathological prospective study based on clinical, electrophysiological, angiographic, and genetic findings
por: Duthoit, Guillaume, et al.
Publicado: (2012)

New Insights into Cardiac and Brain Sodium Channels Modulation by Beta Blockers
por: Chahine, Mohamed
Publicado: (2011)

A New Cardiac Channelopathy: From Clinical Phenotypes to Molecular Mechanisms Associated With Na(v)1.5 Gating Pores
por: Moreau, Adrien, et al.
Publicado: (2018)

Functional Restoration of BRCA1 Nonsense Mutations by Aminoglycoside-Induced Readthrough
por: Abreu, Renata B. V., et al.
Publicado: (2022)

Diagnostic yield and variant reassessment in the genes encoding Nav1.5 channel in Russian patients with Brugada syndrome
por: Zaklyazminskaya, Elena, et al.
Publicado: (2022)

Physiological and Pathophysiological Insights of Nav1.4 and Nav1.5 Comparison
por: Loussouarn, Gildas, et al.
Publicado: (2016)

Targeting the Intracellular Environment in Cystic Fibrosis: Restoring Autophagy as a Novel Strategy to Circumvent the CFTR Defect
por: Villella, Valeria Rachela, et al.
Publicado: (2013)

Management of ventricular tachycardia--role of mexiletine : proceedings of a symposium held in Copenhagen, Denmark, 25th-27th May, 1978 /
Publicado: (1978)

A Case of Mexiletine-induced Hypersensitivity Syndrome Presenting as Eosinophilic Pneumonia
por: Lee, Sang-Pyo, et al.
Publicado: (2010)

Therapeutic drug monitoring of mexiletine at a large academic medical center
por: Nei, Scott D, et al.
Publicado: (2016)

Case report: Mexiletine suppresses ventricular arrhythmias in Andersen-Tawil syndrome
por: Yang, Jing, et al.
Publicado: (2022)

Mexiletine in spinal and bulbar muscular atrophy: a randomized controlled trial
por: Yamada, Shinichiro, et al.
Publicado: (2022)

Effects of Mexiletine on a Race-specific Mutation in Na(v)1.5 Associated With Long QT Syndrome
por: Wu, Xin, et al.
Publicado: (2022)

Recent advances in voltage-gated sodium channels, their pharmacology, and related diseases
por: Desaphy, Jean-François, et al.
Publicado: (2013)

Editorial: Recent Advances in Voltage-Gated Sodium Channels, their Pharmacology and Related Diseases
por: Chahine, Mohamed, et al.
Publicado: (2016)

Membrane Trafficking and Subcellular Drug Targeting Pathways
por: Kumar, Ajay, et al.
Publicado: (2020)

Distinct functional defect of three novel Brugada syndrome related cardiac sodium channel mutations
por: Hsueh, Chia-Hsiang, et al.
Publicado: (2009)

Regulatory Role of Voltage-Gated Na(+) Channel β Subunits in Sensory Neurons
por: Chahine, Mohamed, et al.
Publicado: (2011)

MTSET modification of D4S6 cysteines stabilize the fast inactivated state of Na(v)1.5 sodium channels
por: O’Leary, Michael E., et al.
Publicado: (2015)

Not All Brugada Electrocardiogram Patterns are Brugada Syndrome or Brugada Phenocopy
por: Xu, Grace, et al.
Publicado: (2017)

Mexiletine Treatment for Neonatal LQT3 Syndrome: Case Report and Literature Review
por: Bagkaki, Alena, et al.
Publicado: (2021)

Mexiletine and False Positive Urine Drug Screen for Amphetamine: A Case Review
por: Sohal, Sumit, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m14tlg7u28s8k8eb62pjcscbmc